X

Trial Profile

Clinical trial of Liquid StructureTM Cannabidiol

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 03 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Neuropathic pain
Focus Adverse reactions

Most Recent Events

03 Feb 2021 New trial record
28 Jan 2021 According to an ANANDA Scientific Inc media release, this trial is being conducted at NYU Grossman School of Medicine and funded National Institute on Drug Abuse (NIDA), with additional support from ANANDA Scientific.
28 Jan 2021 According to an ANANDA Scientific Inc media release, an Investigational New Drug (IND) application has been approved by the U.S. Food and Drug Administration (FDA) to initiate this trial and this trial is led by principal investigator Stephen Ross, MD.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com